Tumor website：www.tumorsci.org E-mail Alert
Aumolertinib as a first-line treatment for EGFR-mutated non-small cell lung cancer: a real-world study
GUO Mingyuan, DUAN Xiaoman, WANG Haitao, ZHU Jun, ZHANG Yu, ZHAO Yanbin
Tumor . 2025, (01): 35 -46 .  DOI: 10.3781/j.issn.1000-7431.2025.2403-0169

Copyright © Tumor, All Rights Reserved.
E-mail: tumor@tumorsci.org
Powered by Beijing Magtech Co., Ltd.